Results 81 to 90 of about 7,411 (220)

Long-term safety and tolerability of saxagliptin add-on therapy in older patients (aged ≥65 years) with type 2 diabetes

open access: yesClinical Interventions in Aging, 2014
Nayyar Iqbal,1 Elsie Allen,1 Peter Öhman2 1Bristol-Myers Squibb, Princeton, NJ, USA; 2AstraZeneca, Wilmington, DE, USA Background: Treatment decisions for older patients with type 2 diabetes mellitus must balance glycemic control and adverse event
Iqbal N, Allen E, Öhman P
doaj  

Effects of Dietary Treatment Alone or Diet With Voglibose or Glyburide on Abdominal Adipose Tissue and Metabolic Abnormalities in Patients With Newly Diagnosed Type 2 Diabetes [PDF]

open access: bronze, 2002
Kazuhisa Takami   +11 more
openalex   +1 more source

To study anti-hyperglycemic actions of three indigenous drugs namely Momordica charantia, Gymnema sylvestre and Piper betle

open access: yesNational Journal of Physiology, Pharmacy and Pharmacology
Background: Momordica charantia, Gymnema sylvestre, and Piper betle are developing as optional therapy in type 2 diabetes. Animal studies are helping to reveal its anti-diabetic properties. However, clinical studies in human subjects are few.
Tamoghna Maiti   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy